Novo is trying to respond to compounding pharmacies by starting a cash pay DTC option, similar to what Lilly has done. 

Seems like a wretched sell to me. These are the least effective versions of these drugs, and they are still mind meltingly expensive?

Novo is trying to respond to compounding pharmacies by starting a cash pay DTC option, similar to what Lilly has done. 

Seems like a wretched sell to me. These are the least effective versions of these drugs, and they are still mind meltingly expensive? https://www.washingtonpost.com/business/2025/03/05/novo-nordisk-wegovy-cash-discount/

The Farcaster formerly known as Kchamp. Books, beats, bodybuilding, bright ideas and beautiful things.

katherinechampagne.com

This just highlights how broken the system is, These companies are setting arbitrary prices and reacting only when competition forces them to

I am not educated enough to provide the steelman here against arbitrary pricing — I know there is one — but it’s hard to feel any other way. I will say $500/mo is not even remotely competitive to $HIMS which is <200

Yeah, if $HIMS is offering something for <200, it really exposes how much these big players are relying on their brand and market position rather than actual cost based pricing. I’d love to see more transparency in how these prices are set